Brief: Dynavax Technologies Q2 EPS USD 0.09
06/08/2024 21:01
Aug 06 (Reuters) - Dynavax Technologies Q2 pretax profit USD 14.906 million. * Q2 operating expenses USD 68.597 million * Q2 net income USD 11.386 million * Q2 operating income USD 5.198 million
Recent news on Dynavax Technologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
OneSpaWorld jumps as co poised to join S&P SmallCap index
Sanofi targets high single digit sales growth in 2026, plans share buyback (updated)
Focus: Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality